Cellectis SA (CLLS)
3.24
-0.08
(-2.41%)
USD |
NASDAQ |
Sep 04, 16:00
3.24
0.00 (0.00%)
After-Hours: 20:00
Cellectis SG&A Expense (TTM) : 21.32M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 21.32M |
| March 31, 2026 | 20.74M |
| December 31, 2025 | 19.83M |
| September 30, 2025 | 19.93M |
| June 30, 2025 | 19.93M |
| March 31, 2025 | 18.67M |
| December 31, 2024 | 19.06M |
| September 30, 2024 | 18.84M |
| June 30, 2024 | 16.88M |
| March 31, 2024 | 16.95M |
| December 31, 2023 | 16.81M |
| September 30, 2023 | 13.84M |
| June 30, 2023 | 15.52M |
| March 31, 2023 | 16.40M |
| December 31, 2022 | 17.49M |
| September 30, 2022 | 25.77M |
| June 30, 2022 | 30.54M |
| March 31, 2022 | 35.06M |
| December 31, 2021 | 37.77M |
| September 30, 2021 | 40.23M |
| June 30, 2021 | 40.86M |
| March 31, 2021 | 40.59M |
| December 31, 2020 | 43.95M |
| Date | Value |
|---|---|
| September 30, 2020 | 40.29M |
| June 30, 2020 | 40.96M |
| March 31, 2020 | 43.70M |
| December 31, 2019 | 43.05M |
| September 30, 2019 | 44.79M |
| June 30, 2019 | 45.38M |
| March 31, 2019 | 44.82M |
| December 31, 2018 | 47.34M |
| September 30, 2018 | 49.82M |
| June 30, 2018 | 51.17M |
| March 31, 2018 | 49.94M |
| December 31, 2017 | 46.30M |
| September 30, 2017 | 45.59M |
| June 30, 2017 | 43.53M |
| March 31, 2017 | 43.22M |
| December 31, 2016 | 44.45M |
| September 30, 2016 | 41.03M |
| June 30, 2016 | 40.85M |
| March 31, 2016 | 41.19M |
| December 31, 2015 | 37.67M |
| September 30, 2015 | 28.81M |
| June 30, 2015 | 18.14M |
| March 31, 2015 | 8.088M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| DBV Technologies SA | 56.62M |
| Akari Therapeutics Plc | 8.796M |
| EDAP TMS SA | 26.00M |
| Autolus Therapeutics Plc | 152.92M |
| Evaxion AS | 4.527M |